In the present study, we systematically analyzed dysregulated TFs in GC and identified a critical role of transcriptional factor PLXNC1 in promoting GC progression, as well as the prognostic value of PLXNC1 in GC patients. This evidence concerns the gene PLXNC1 and gastric cancer.